About: Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.13 (-2.59%)
PLRXNASDAQPliant Therapeutics Inc
Pliant Therapeutics Inc share price
PLRX price activity
Last Price
$1.130
Change (24hr)
-0.03 USD (-2.59%)
Volume
100.13K
Volume (4w avg)
-
Open
$1.11
Day Range
$1.11 - $1.15
Previous Close
$1.16
Last Trade
08 Sep, 1:52 pm GMT+0
Delayed
08 Sep, 1:52 pm GMT+0
PLRX price performance
Delayed
08 Sep, 1:52 pm GMT+0
PLRX Market Signals